Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Prog Neuropsychopharmacol Biol Psychiatry ; 33(7): 1191-9, 2009 Oct 01.
Article in English | MEDLINE | ID: mdl-19580839

ABSTRACT

Acetaminophen (Paracetamol), a most commonly used antipyretic/analgesic agent, is metabolized to AM404 (N-arachidonoylphenolamine) that inhibits uptake and degradation of anandamide which is reported to mediate the analgesic action of acetaminophen via CB1 receptor. AM404 and anandamide are also reported to produce anxiolytic-like behavior. In view of the implication of endocannabinoids in the effect of acetaminophen, we contemplated that acetaminophen may have anxiolytic-like effect. Therefore, this possibility was tested by observing the effects of various doses of acetaminophen in mice on anxiety-related indices of Vogel conflict test and social interaction test. The results from both the tests indicated that acetaminophen (50, 100, or 200 mg/kg, i.p.) or anandamide (10 or 20 microg/mouse, i.c.v.) dose dependently elicited anxiolytic-like effect, that was comparable to diazepam (2 mg/kg, i.p.). Moreover, co-administration of sub-effective dose of acetaminophen (25 mg/kg, i.p.) and anandamide (5 microg/mouse, i.c.v) produced similar anxiolytic effect. Further, pre-treatment with AM251 (a CB1 receptor antagonist; 1 mg/kg, i.p.) antagonized the effects of acetaminophen and anandamide with no per se effect at 1 mg/kg dose, while anxiogenic effect was evident at a higher dose (5 mg/kg, i.p.). None of the treatment/s was found to induce any antinociceptive or locomotor impairment effects. In conclusion, the findings suggested that acetaminophen (50, 100, or 200 mg/kg, i.p.) exhibited dose dependent anxiolytic effect in mice and probably involved endocannabinoid-mediated mechanism in its effect.


Subject(s)
Acetaminophen/administration & dosage , Anti-Anxiety Agents/administration & dosage , Anxiety/drug therapy , Cannabinoid Receptor Modulators/metabolism , Endocannabinoids , Receptor, Cannabinoid, CB1/metabolism , Animals , Arachidonic Acids/pharmacology , Behavior, Animal/drug effects , Cannabinoid Receptor Modulators/pharmacology , Diazepam/pharmacology , Disease Models, Animal , Dose-Response Relationship, Drug , Drinking/drug effects , Injections, Intraventricular/methods , Interpersonal Relations , Male , Mice , Motor Activity/drug effects , Piperidines/pharmacokinetics , Polyunsaturated Alkamides/pharmacology , Pyrazoles/pharmacokinetics , Receptor, Cannabinoid, CB1/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...